首页 › 膀胱癌 › 加利福尼亚州 › San Francisco
San Francisco CA 膀胱癌临床试验
13项针对 膀胱癌的研究正在 San Francisco及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
招募中1/2 期
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
招募中1/2 期
- University of California, San Francisco, San Francisco
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
招募中1 期
- University of California, San Francisco, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- UCSF Medical Center at Mission Bay, San Francisco
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
招募中1 期
- UCSF Medical center Parnassus, San Francisco
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
招募中2/3 期
- Pacific Hematology Oncology Associates, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
招募中2 期
- UCSF Cancer Center MZ Phlebotomy, San Francisco
- UCSF Mount Zion Phlebotomy, San Francisco
- UCSF Parnassus Phlebotomy, San Francisco
- 以及另外 3 项
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
招募中3 期
- Research Site, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- University of California San Francisco, San Francisco
Blue Light Cystoscopy With Cysview® Registry
招募中观察性研究
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, San Francisco
其他城市的 膀胱癌试验
- New York City, NY35 项研究
- Houston, TX31 项研究
- Nashville, TN31 项研究
- Dallas, TX27 项研究
- Washington, DC26 项研究
- Boston, MA26 项研究
- Baltimore, MD24 项研究
- Los Angeles, CA24 项研究
- St. Louis, MO22 项研究
- Seattle, WA21 项研究
- Edison, NJ21 项研究
- Philadelphia, PA21 项研究
San Francisco的其他研究
- 前列腺癌45 项研究
- 乳腺癌43 项研究
- 非小细胞肺癌36 项研究
- 癌症（所有类型）35 项研究
- 心力衰竭29 项研究
- 转移性癌症28 项研究
- 肺癌22 项研究
- 黑色素瘤22 项研究
- 胰腺癌20 项研究
- 卵巢癌19 项研究
- 结直肠癌18 项研究
- 心血管疾病18 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。